Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development
Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1‐AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatic...
Saved in:
Published in | Molecular carcinogenesis Vol. 54; no. 11; pp. 1275 - 1282 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.11.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1‐AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1‐AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1‐AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case‐control study of 1300 HBV‐positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1‐AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01–1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71–0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC. © 2014 Wiley Periodicals, Inc. |
---|---|
AbstractList | Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1‐AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1‐AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1‐AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case‐control study of 1300 HBV‐positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1‐AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01–1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71–0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC. © 2014 Wiley Periodicals, Inc. Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1-AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1-AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1-AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case-control study of 1300 HBV-positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1-AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR=1.18, 95% CI=1.01-1.38, P=0.035) and HBV clearance (adjusted OR=0.83, 95% CI=0.71-0.96, P=0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC. Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1-AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1-AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1-AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case-control study of 1300 HBV-positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1-AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01-1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71-0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC.Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune response against HBV infection and hepatocarcinogenesis. ZNRD1-AS1 (ZNRD1 antisense RNA 1) may be an important regulator of ZNRD1. By bioinformatics analyses, we identified that several single nucleotide polymorphisms (SNPs) in ZNRD1-AS1 may be expression quantitative trait loci (eQTLs) for ZNRD1. In this study, we hypothesized that these eQTLs SNPs in ZNRD1-AS1 may influence both chronic HBV infection and hepatocellular carcinoma (HCC) development. We designed a case-control study of 1300 HBV-positive HCC patients, 1344 HBV persistent carriers and, 1344 HBV natural clearance subjects to test the associations of three ZNRD1 eQTLs SNPs (rs3757328, rs6940552 and, rs9261204) in ZNRD1-AS1 with the risk of both chronic HBV infection and HCC. Logistic regression analyses in additive genetic model showed that variant alleles of all the three SNPs increased host HCC risk, whereas variant allele of rs3757328 was associated with HBV clearance. Moreover, the haplotype containing variant alleles of the three SNPs was significantly associated with both HCC development (adjusted OR = 1.18, 95% CI = 1.01-1.38, P = 0.035) and HBV clearance (adjusted OR = 0.83, 95% CI = 0.71-0.96, P = 0.013), when compared with the most frequent haplotype. In vitro experiments showed that ZNRD1 knockdown inhibited the expression of HBV mRNA and promoted proliferation of HepG2.2.15 cells. These findings suggest that ZNRD1 regulatory SNPs may be susceptibility makers for risk of both chronic HBV infection and HCC. |
Author | Liu, Yao Liu, Li Shen, Hongbin Liu, Jibin Song, Ci Hu, Zhibin Wang, Cheng Han, Jing Zhu, Liguo Zhai, Xiangjun Wen, Juan Chen, Jianguo |
Author_xml | – sequence: 1 givenname: Juan surname: Wen fullname: Wen, Juan organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China – sequence: 2 givenname: Yao surname: Liu fullname: Liu, Yao organization: Pathology Center and Department of Pathology, Soochow University, Suzhou, China – sequence: 3 givenname: Jibin surname: Liu fullname: Liu, Jibin organization: Department of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, China – sequence: 4 givenname: Li surname: Liu fullname: Liu, Li organization: Digestive Endoscopy Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China – sequence: 5 givenname: Ci surname: Song fullname: Song, Ci organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China – sequence: 6 givenname: Jing surname: Han fullname: Han, Jing organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China – sequence: 7 givenname: Liguo surname: Zhu fullname: Zhu, Liguo organization: Department of Infection Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China – sequence: 8 givenname: Cheng surname: Wang fullname: Wang, Cheng organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China – sequence: 9 givenname: Jianguo surname: Chen fullname: Chen, Jianguo organization: Qidong Liver Cancer Institute, Qidong, China – sequence: 10 givenname: Xiangjun surname: Zhai fullname: Zhai, Xiangjun organization: Department of Infection Diseases, Jiangsu Province Center for Disease Prevention and Control, Nanjing, China – sequence: 11 givenname: Hongbin surname: Shen fullname: Shen, Hongbin organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China – sequence: 12 givenname: Zhibin surname: Hu fullname: Hu, Zhibin organization: Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25110835$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0d1u0zAUB3ALDbFuIPEEyBI33KTYjpM4l6X7KFUp0gZM4sZynRPmkdiZ7YztEXhrkm4MqQKJK3_od86x9T9Ae9ZZQOglJVNKCHvb6iljjJAnaEJJKRJWcL6HJkSUZUJLUeyjgxCuCKG0yMgztM8ySolIswn6eXzbeQjBOIuve2WjiSqaG8DRKxNx47TBxg6r_YaHoYl2lRm2Z-sZ_ro-O6LJ7JwOoG56sBrwxsVLvHj3ZbwCHceuylb4EjoVnYam6RvlsVZeG-tahSu4gcZ1Ldj4HD2tVRPgxcN6iD6fHH-aL5LVx9P389kq0VzkJCk16IpzVeucKVaTIieiprqGTZ3RTBVa0JpkoLQG4GLDSQk1qYrhKFJFNE8P0Zv7vp131z2EKFsTxqcpC64PkhYpEzRLCfsPyliZUpaWA329Q69c7-3wka1iecq5GNSrB9VvWqhk502r_J38ncefidq7EDzUj4QSOUYtWy23UQ90ukP1Njtnx-iavxUk9wU_TAN3_2wsP8x3vAkRbh-98t9lXqRFJi_Wp_JiuVyx5eJEnqe_AGpkyBM |
CitedBy_id | crossref_primary_10_1371_journal_pone_0132352 crossref_primary_10_1667_RADE_20_00157_1 crossref_primary_10_1177_1179299X17737301 crossref_primary_10_18632_oncotarget_8411 crossref_primary_10_1016_j_mrrev_2016_10_002 crossref_primary_10_1038_s41598_018_26217_7 crossref_primary_10_1002_cam4_2160 crossref_primary_10_1186_s12885_018_4795_6 crossref_primary_10_2147_OTT_S250028 crossref_primary_10_1002_cam4_3373 crossref_primary_10_18632_aging_205523 crossref_primary_10_1186_s12876_023_02961_7 crossref_primary_10_1111_jvh_12821 crossref_primary_10_1089_gtmb_2021_0053 crossref_primary_10_18632_oncotarget_14334 crossref_primary_10_3892_ijo_2019_4909 crossref_primary_10_18632_oncotarget_10012 crossref_primary_10_3389_fviro_2022_849349 crossref_primary_10_4254_wjh_v7_i28_2781 crossref_primary_10_1002_hep_31284 crossref_primary_10_3389_fgene_2019_00696 crossref_primary_10_2147_PGPM_S325349 crossref_primary_10_18632_oncotarget_9854 crossref_primary_10_2147_JIR_S331727 crossref_primary_10_3748_wjg_v28_i25_2823 crossref_primary_10_1038_srep39516 crossref_primary_10_1371_journal_pone_0173700 crossref_primary_10_7717_peerj_9452 crossref_primary_10_1038_s41588_019_0455_2 crossref_primary_10_1093_bib_bbae327 crossref_primary_10_7717_peerj_8624 |
Cites_doi | 10.1038/nbt.1663 10.1016/j.ccr.2008.10.005 10.1016/j.ajpath.2012.08.043 10.1038/ng.2483 10.1016/j.ccr.2012.01.001 10.1002/path.4195 10.1371/journal.pone.0035145 10.1093/hmg/ddr301 10.4161/cbt.4.1.1375 10.1002/hep.24563 10.4065/82.8.967 10.1038/ng.348 10.1128/JVI.02655-12 10.1101/gad.1800909 10.1053/j.gastro.2006.08.026 10.1111/j.1442-2050.2008.00846.x 10.1038/ng2142 10.1371/journal.pgen.1000214 10.1126/science.1143767 10.1016/j.jhep.2012.04.031 10.1053/j.gastro.2013.01.002 10.1016/S0140-6736(03)14964-1 10.1086/651114 10.1002/hep.24799 10.1110/ps.9.9.1743 10.1006/geno.1999.6040 10.1111/j.1399-0039.2004.00327.x 10.1042/CBI20100506 10.1006/jmbi.2000.3841 10.1159/000336913 10.1038/nature06904 10.1016/j.molcel.2009.08.008 |
ContentType | Journal Article |
Copyright | 2014 Wiley Periodicals, Inc. 2015 Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2014 Wiley Periodicals, Inc. – notice: 2015 Wiley Periodicals, Inc. |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 7TO 8FD FR3 H94 P64 RC3 7X8 7U9 |
DOI | 10.1002/mc.22200 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic Virology and AIDS Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic Virology and AIDS Abstracts |
DatabaseTitleList | Genetics Abstracts Genetics Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-2744 |
EndPage | 1282 |
ExternalDocumentID | 3837274601 25110835 10_1002_mc_22200 MC22200 ark_67375_WNG_WJJL2JHF_S |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Jiangsu Province Clinical Science and Technology Projects funderid: BL2012008 – fundername: National Key Basic Research Program For Youth funderid: 2013CB911400 – fundername: National Science Foundation for Distinguished Young Scholars of China funderid: 81225020 – fundername: Foundation for the Program for New Century Excellent Talents in University funderid: NCET‐10‐0178 – fundername: Foundation of Jiangsu Province for Distinguished Young Scholars funderid: BK2012042 – fundername: National Program for Support of Top‐notch Young Professionals, Foundation for the Author of National Excellent Doctoral Dissertation funderid: 201081 – fundername: Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province – fundername: Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine) |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GLUZI GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IH2 IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7TM 7TO 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 P64 RC3 7X8 7U9 |
ID | FETCH-LOGICAL-c4860-9cecd44afc62a2f07608f1cfebf515a7c81f05eaccee48b409ef0d7cce83a0c43 |
IEDL.DBID | DR2 |
ISSN | 0899-1987 1098-2744 |
IngestDate | Thu Jul 10 21:45:45 EDT 2025 Thu Jul 10 22:39:34 EDT 2025 Sun Jul 13 04:30:21 EDT 2025 Thu Apr 03 06:52:49 EDT 2025 Thu Apr 24 23:00:37 EDT 2025 Tue Jul 01 00:38:38 EDT 2025 Wed Jan 22 16:20:00 EST 2025 Wed Oct 30 09:56:27 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | HCC eQTLs ZNRD1 susceptibility |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2014 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4860-9cecd44afc62a2f07608f1cfebf515a7c81f05eaccee48b409ef0d7cce83a0c43 |
Notes | ark:/67375/WNG-WJJL2JHF-S ArticleID:MC22200 National Science Foundation for Distinguished Young Scholars of China - No. 81225020 Foundation for the Program for New Century Excellent Talents in University - No. NCET-10-0178 Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine) National Key Basic Research Program For Youth - No. 2013CB911400 Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province Foundation of Jiangsu Province for Distinguished Young Scholars - No. BK2012042 istex:44C4E6D95413A97042BF87E9CEEB8EED7854B9C9 National Program for Support of Top-notch Young Professionals, Foundation for the Author of National Excellent Doctoral Dissertation - No. 201081 Jiangsu Province Clinical Science and Technology Projects - No. BL2012008 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25110835 |
PQID | 1722263448 |
PQPubID | 105347 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1732815302 proquest_miscellaneous_1722931239 proquest_journals_1722263448 pubmed_primary_25110835 crossref_primary_10_1002_mc_22200 crossref_citationtrail_10_1002_mc_22200 wiley_primary_10_1002_mc_22200_MC22200 istex_primary_ark_67375_WNG_WJJL2JHF_S |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2015 |
PublicationDateYYYYMMDD | 2015-11-01 |
PublicationDate_xml | – month: 11 year: 2015 text: November 2015 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Austin |
PublicationTitle | Molecular carcinogenesis |
PublicationTitleAlternate | Mol. Carcinog |
PublicationYear | 2015 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494-1504. Grishin NV. C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily. J Mol Biol 2000; 299:1165-1177. Hu L, Zhai X, Liu J, et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012; 55:1426-1431. Juan AH, Kumar RM, Marx JG, et al. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36:61-74. Hong L, Han Y, Li S, et al. Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011; 35:321-324. Shih TC, Tien YJ, Wen CJ, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012; 57:584-591. Tam OH, Aravin AA, Stein P, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008; 453:534-538. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-595. Feng GS. Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox. Cancer Cell 2012; 21:150-154. Szabo G, Lippai D. Molecular hepatic carcinogenesis: impact of inflammation. Dig Dis 2012; 30:243-248. Hong L, Han Y, Shi R, et al. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005; 4:60-64. Wurdinger T, Tannous BA, Saydam O, et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14:382-393. Guo W, Zhao YP, Jiang YG, et al. ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus 2008; 21:730-736. Holt N, Wang J, Kim K, et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28:839-847. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947. Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 2013; 144:512-527. Zheng Z, Ke X, Wang M, et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 2013; 87:5645-5656. Chung YL, Wu ML. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis. J Pathol 2013; 230:377-387. Veyrieras JB, Kudaravalli S, Kim SY, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4:e1000214. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917. Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007; 39:1217-1224. Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132:330-342. Fan W, Wang Z, Kyzysztof F, et al. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region. Genomics 2000; 63:139-141. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64:631-649. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82:967-975. Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54:1679-1689. Jiang DK, Sun J, Cao G, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45:72-75. Chen HT, Legault P, Glushka J, et al. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription. Protein Sci 2000; 9:1743-1752. Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011; 20:3884-3892. Ballana E, Senserrich J, Pauls E, et al. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 2010; 50:1022-1032. Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 2013; 182:21-28. Liu Y, Pan S, Liu L, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012; 7:e35145. 2009; 23 2007; 39 2004; 64 2009; 41 2013; 87 2013; 45 2000; 9 2000; 63 2008; 14 2013; 144 2011; 54 2011; 35 2000; 299 2008; 4 2012; 57 2012; 55 2013; 182 2012; 30 2009; 36 2007; 317 2010; 28 2007; 132 2011; 20 2005; 4 2007; 82 2008; 21 2013; 230 2008; 453 2012; 7 2012; 21 2003; 362 2010; 50 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 |
References_xml | – reference: Hu L, Zhai X, Liu J, et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012; 55:1426-1431. – reference: Wurdinger T, Tannous BA, Saydam O, et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14:382-393. – reference: Szabo G, Lippai D. Molecular hepatic carcinogenesis: impact of inflammation. Dig Dis 2012; 30:243-248. – reference: Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 2013; 182:21-28. – reference: Tam OH, Aravin AA, Stein P, et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008; 453:534-538. – reference: Juan AH, Kumar RM, Marx JG, et al. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009; 36:61-74. – reference: Zheng Z, Ke X, Wang M, et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 2013; 87:5645-5656. – reference: Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-595. – reference: Feng GS. Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox. Cancer Cell 2012; 21:150-154. – reference: Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947. – reference: Mbarek H, Ochi H, Urabe Y, et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 2011; 20:3884-3892. – reference: Liu Y, Pan S, Liu L, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012; 7:e35145. – reference: Hong L, Han Y, Shi R, et al. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005; 4:60-64. – reference: Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007; 39:1217-1224. – reference: Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54:1679-1689. – reference: Guo W, Zhao YP, Jiang YG, et al. ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus 2008; 21:730-736. – reference: Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23:1494-1504. – reference: Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64:631-649. – reference: Shih TC, Tien YJ, Wen CJ, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012; 57:584-591. – reference: Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917. – reference: Veyrieras JB, Kudaravalli S, Kim SY, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4:e1000214. – reference: Panzitt K, Tschernatsch MM, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132:330-342. – reference: Ballana E, Senserrich J, Pauls E, et al. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 2010; 50:1022-1032. – reference: Hong L, Han Y, Li S, et al. Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011; 35:321-324. – reference: Jiang DK, Sun J, Cao G, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 2013; 45:72-75. – reference: Grishin NV. C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily. J Mol Biol 2000; 299:1165-1177. – reference: Hernandez-Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 2013; 144:512-527. – reference: Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82:967-975. – reference: Chen HT, Legault P, Glushka J, et al. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription. Protein Sci 2000; 9:1743-1752. – reference: Holt N, Wang J, Kim K, et al. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28:839-847. – reference: Chung YL, Wu ML. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis. J Pathol 2013; 230:377-387. – reference: Fan W, Wang Z, Kyzysztof F, et al. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region. Genomics 2000; 63:139-141. – volume: 57 start-page: 584 year: 2012 end-page: 591 article-title: MicroRNA‐214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma‐derived growth factor in human hepatoma publication-title: J Hepatol – volume: 453 start-page: 534 year: 2008 end-page: 538 article-title: Pseudogene‐derived small interfering RNAs regulate gene expression in mouse oocytes publication-title: Nature – volume: 21 start-page: 730 year: 2008 end-page: 736 article-title: ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1 publication-title: Dis Esophagus – volume: 63 start-page: 139 year: 2000 end-page: 141 article-title: A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region publication-title: Genomics – volume: 20 start-page: 3884 year: 2011 end-page: 3892 article-title: A genome‐wide association study of chronic hepatitis B identified novel risk locus in a Japanese population publication-title: Hum Mol Genet – volume: 39 start-page: 1217 year: 2007 end-page: 1224 article-title: Population genomics of human gene expression publication-title: Nat Genet – volume: 28 start-page: 839 year: 2010 end-page: 847 article-title: Human hematopoietic stem/progenitor cells modified by zinc‐finger nucleases targeted to CCR5 control HIV‐1 in vivo publication-title: Nat Biotechnol – volume: 54 start-page: 1679 year: 2011 end-page: 1689 article-title: Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans publication-title: Hepatology – volume: 82 start-page: 967 year: 2007 end-page: 975 article-title: Natural history of hepatitis B virus infection: an update for clinicians publication-title: Mayo Clin Proc – volume: 317 start-page: 944 year: 2007 end-page: 947 article-title: A whole‐genome association study of major determinants for host control of HIV‐1 publication-title: Science – volume: 299 start-page: 1165 year: 2000 end-page: 1177 article-title: C‐terminal domains of Escherichia coli topoisomerase I belong to the zinc‐ribbon superfamily publication-title: J Mol Biol – volume: 230 start-page: 377 year: 2013 end-page: 387 article-title: Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus‐related hepatocarcinogenesis publication-title: J Pathol – volume: 9 start-page: 1743 year: 2000 end-page: 1752 article-title: Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription publication-title: Protein Sci – volume: 4 start-page: e1000214 year: 2008 article-title: High‐resolution mapping of expression‐QTLs yields insight into human gene regulation publication-title: PLoS Genet – volume: 23 start-page: 1494 year: 2009 end-page: 1504 article-title: Long noncoding RNAs: functional surprises from the RNA world publication-title: Genes Dev – volume: 30 start-page: 243 year: 2012 end-page: 248 article-title: Molecular hepatic carcinogenesis: impact of inflammation publication-title: Dig Dis – volume: 87 start-page: 5645 year: 2013 end-page: 5656 article-title: Human microRNA hsa‐miR‐296‐5p suppresses enterovirus 71 replication by targeting the viral genome publication-title: J Virol – volume: 7 start-page: e35145 year: 2012 article-title: A genetic variant in long non‐coding RNA HULC contributes to risk of HBV‐related hepatocellular carcinoma in a Chinese population publication-title: PLoS One – volume: 55 start-page: 1426 year: 2012 end-page: 1431 article-title: Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development publication-title: Hepatology – volume: 132 start-page: 330 year: 2007 end-page: 342 article-title: Characterization of HULC, a novel gene with striking up‐regulation in hepatocellular carcinoma, as noncoding RNA publication-title: Gastroenterology – volume: 362 start-page: 1907 year: 2003 end-page: 1917 article-title: Hepatocellular carcinoma publication-title: Lancet – volume: 4 start-page: 60 year: 2005 end-page: 64 article-title: ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase publication-title: Cancer Biol Ther – volume: 41 start-page: 591 year: 2009 end-page: 595 article-title: A genome‐wide association study identifies variants in the HLA‐DP locus associated with chronic hepatitis B in Asians publication-title: Nat Genet – volume: 21 start-page: 150 year: 2012 end-page: 154 article-title: Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox publication-title: Cancer Cell – volume: 182 start-page: 21 year: 2013 end-page: 28 article-title: Protective and pathological properties of IL‐22 in liver disease: implications for viral hepatitis publication-title: Am J Pathol – volume: 64 start-page: 631 year: 2004 end-page: 649 article-title: An update of the HLA genomic region, locus information and disease associations: 2004 publication-title: Tissue Antigens – volume: 144 start-page: 512 year: 2013 end-page: 527 article-title: Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma publication-title: Gastroenterology – volume: 45 start-page: 72 year: 2013 end-page: 75 article-title: Genetic variants in STAT4 and HLA‐DQ genes confer risk of hepatitis B virus‐related hepatocellular carcinoma publication-title: Nat Genet – volume: 36 start-page: 61 year: 2009 end-page: 74 article-title: Mir‐214‐dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells publication-title: Mol Cell – volume: 35 start-page: 321 year: 2011 end-page: 324 article-title: Role of ZNRD1 (zinc ribbon domain‐containing 1) in angiogenesis of leukaemia cells publication-title: Cell Biol Int – volume: 50 start-page: 1022 year: 2010 end-page: 1032 article-title: ZNRD1 (zinc ribbon domain‐containing 1) is a host cellular factor that influences HIV‐1 replication and disease progression publication-title: Clin Infect Dis – volume: 14 start-page: 382 year: 2008 end-page: 393 article-title: miR‐296 regulates growth factor receptor overexpression in angiogenic endothelial cells publication-title: Cancer Cell – ident: e_1_2_7_13_1 doi: 10.1038/nbt.1663 – ident: e_1_2_7_23_1 doi: 10.1016/j.ccr.2008.10.005 – ident: e_1_2_7_27_1 doi: 10.1016/j.ajpath.2012.08.043 – ident: e_1_2_7_12_1 doi: 10.1038/ng.2483 – ident: e_1_2_7_33_1 doi: 10.1016/j.ccr.2012.01.001 – ident: e_1_2_7_28_1 doi: 10.1002/path.4195 – ident: e_1_2_7_31_1 doi: 10.1371/journal.pone.0035145 – ident: e_1_2_7_11_1 doi: 10.1093/hmg/ddr301 – ident: e_1_2_7_17_1 doi: 10.4161/cbt.4.1.1375 – ident: e_1_2_7_30_1 doi: 10.1002/hep.24563 – ident: e_1_2_7_4_1 doi: 10.4065/82.8.967 – ident: e_1_2_7_10_1 doi: 10.1038/ng.348 – ident: e_1_2_7_20_1 doi: 10.1128/JVI.02655-12 – ident: e_1_2_7_21_1 doi: 10.1101/gad.1800909 – ident: e_1_2_7_29_1 doi: 10.1053/j.gastro.2006.08.026 – ident: e_1_2_7_16_1 doi: 10.1111/j.1442-2050.2008.00846.x – ident: e_1_2_7_25_1 doi: 10.1038/ng2142 – ident: e_1_2_7_24_1 doi: 10.1371/journal.pgen.1000214 – ident: e_1_2_7_15_1 doi: 10.1126/science.1143767 – ident: e_1_2_7_19_1 doi: 10.1016/j.jhep.2012.04.031 – ident: e_1_2_7_3_1 doi: 10.1053/j.gastro.2013.01.002 – ident: e_1_2_7_2_1 doi: 10.1016/S0140-6736(03)14964-1 – ident: e_1_2_7_14_1 doi: 10.1086/651114 – ident: e_1_2_7_9_1 doi: 10.1002/hep.24799 – ident: e_1_2_7_5_1 doi: 10.1110/ps.9.9.1743 – ident: e_1_2_7_8_1 doi: 10.1006/geno.1999.6040 – ident: e_1_2_7_7_1 doi: 10.1111/j.1399-0039.2004.00327.x – ident: e_1_2_7_18_1 doi: 10.1042/CBI20100506 – ident: e_1_2_7_6_1 doi: 10.1006/jmbi.2000.3841 – ident: e_1_2_7_26_1 doi: 10.1159/000336913 – ident: e_1_2_7_22_1 doi: 10.1038/nature06904 – ident: e_1_2_7_32_1 doi: 10.1016/j.molcel.2009.08.008 |
SSID | ssj0011750 |
Score | 2.281761 |
Snippet | Zinc ribbon domain containing 1 (ZNRD1), cloned from human leukocyte antigen (HLA) region, may play integral roles in diverse processes including immune... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1275 |
SubjectTerms | Alleles Carcinoma, Hepatocellular - genetics Case-Control Studies Cell Line, Tumor DNA-Binding Proteins - genetics eQTLs Female Gene loci Genetic Predisposition to Disease - genetics Genotype HCC Hep G2 Cells Hepatitis Hepatitis B virus Hepatitis B virus - pathogenicity Hepatitis B, Chronic - genetics Hepatitis B, Chronic - virology Humans Liver cancer Liver Neoplasms - genetics Male Middle Aged Polymorphism, Single Nucleotide - genetics Quantitative Trait Loci - genetics Ribonucleic acid RNA RNA, Antisense - genetics RNA, Long Noncoding - genetics RNA, Messenger - genetics susceptibility ZNRD1 |
Title | Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development |
URI | https://api.istex.fr/ark:/67375/WNG-WJJL2JHF-S/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmc.22200 https://www.ncbi.nlm.nih.gov/pubmed/25110835 https://www.proquest.com/docview/1722263448 https://www.proquest.com/docview/1722931239 https://www.proquest.com/docview/1732815302 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NbxMxEB2hIhAXPgqUQEFGQnDadD-cZHMMpSGKSA4ppRUcLNtrQ1XihXYjFU78ASR-I7-EGXt3q6KCEKdVkoky64z93qyfZwCeaERlnWkZ5VxmEe0ERnmW9EkJwA1HhFW-1-Fs3p_s8elB76BWVdJZmFAfon3gRjPDr9c0waU62TorGrrUXcS2mNJ1kmoRH1q0laOoAKV_vILpRER5dVN3Nk63mi-eQ6LLNKinF9HM86zVw874BrxrHA5qk6PuqlJd_fW3Wo7_d0c34XrNRtkohM8tuGTcOlwJ_Sm_rMPVWb3zfhu-75zWklnHPq-k82fTcKVk1GOiYgiJh-zQ4dW9Z650P7_90CXBIlvMR-ztfPEiwbdGuwka1V1RmMIgYZPnb1gjCHNMuoJ9QICsStpQIIUs09TsyJVLyYozfdMd2BvvvN6eRHUrh0hTl6toqI0uOJdW91OZWtoOzG2irVEWCZUc6DyxcQ9BADGb5wqTTmPjYoAv80zGmmd3YQ2dN_eAGW4xKy0GfUk7hgUJZZQcIu1KLJE_1YFnzd8qdF3nnIbiowgVmlOx1MKPcwcet5afQm2PC2ye-shoDeTxEWnhBj2xP38p9qfTV-l0Mha7HdhsQkfUy8CJQHaI9DbDFBh_q_0YJzANonSmXAUbdD7Nhn-zydI8oQZPHdgIYdk6RDki8Wj01AfXH29FzLb99f6_Gj6Aa0gPe-Hk5SasVccr8xApWKUe-cn2C9VSLH4 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED9Nm4C9DBgwCgOMhOApXf61TcVTGSuhtHnoNjZNSJbjOGza6oyRSoMnvgASn5FPwp2dZBoaCPEUpb2oF_fs3-985zuAZxJRWQZSOFEoAocigU4UeF3KBAhViAibml6Hk6Qb74aj_c7-Arysz8LY-hDNhhvNDLNe0wSnDemNi6qhM9lGcHPRX1-iht7Gn5o2taOoBKXZYEGHwiHPuq486_ob9ZOXsGiJhvX8KqJ5mbca4BnehA-1yjbf5Lg9L9O2_PpbNcf_fKdbsFIRUjawFnQbFpRehWu2ReWXVbg-qYLvd-D71nmVNavZp7nQ5ngaLpaM2kyUDFHxiB1pvOqPTBf657cfsiBkZNNkwA6S6WsPPxpseyhUNUZhKdoJi1-9Z3VOmGZCZ-wQMbIsKKZASbJMUr8jXcwEyy5SnO7C7nBrZzN2qm4OjqRGV05fKpmFochl1xd-ThHBKPdkrtIcOZXoycjL3Q7iAMJ2GKXod6rczXp4GwXClWFwDxZReXUfmApzdEyzXldQ0DCjXJlU9JF5eTnxv7QFL-r_lcuq1DkNxQm3RZp9PpPcjHMLnjaSp7a8xxUyz41pNALi7JjS4Xodvpe84Xuj0dgfxUO-3YL12nZ4tRJ85kgQkeEG6AXjbzVf4xymQRRaFXMrg8r7Qf9vMoEfedTjqQVr1i4bhchNJCqNmhrr-uOr8MmmuT74V8EncCPemYz5-G3y7iEsI1vs2IOY67BYns3VI2RkZfrYzLxfek0wmQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6hVlRceJRXoMAiITg59SuJcwxNQwiNhVJKq3JYrde7bVWyLsWRCif-ABK_kV_CzK7tqqggxMlKMo7H69n9vvHMzgA8k4jKMpLCS2IReRQJ9JIo6FImQKxiRNjM9jqcpt3xTjzZ6-xVWZW0F8bVh2heuNHMsOs1TfCTXK-fFw2dyzZim4_u-jL-Z0IWPZw1paOoAqV9v4L-hEeOdV141g_X6zMvQNEyjerZZTzzIm21uDO6AR9qjV26yXF7UWZt-fW3Yo7_d0s34XpFR9nA2c8tuKLMKlx1DSq_rMLKtAq934bvm2dVzqxhnxbC2M1puFQyajJRMsTEI3Zk8GgOmCnMz28_ZEG4yGbpgO2ns2GAXw22AxSq2qKwDK2EjV--Z3VGmGHC5OwQEbIsKKJAKbJMUrcjU8wFy88TnO7Azmjz3cbYq3o5eJLaXHl9qWQex0LLbihCTfHARAdSq0wjoxI9mQTa7yAKIGjHSYZep9J-3sOPSSR8GUd3YQmVV_eBqVijW5r3uoJChjllymSij7wr0MT-sha8qB8rl1WhcxqKj9yVaA75XHI7zi142kieuOIel8g8t5bRCIjTY0qG63X4bvqK704mW-FkPOLbLVirTYdX68BnjvQQ-W2EPjBeq_kZZzANojCqWDgZVD6M-n-TicIkoA5PLbjnzLJRiJxEItKoqTWuP94Kn27Y44N_FXwCK2-HI771On3zEK4hVey4XZhrsFSeLtQjpGNl9tjOu1_m8S9R |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+quantitative+trait+loci+in+long+non-coding+RNA+ZNRD1-AS1+influence+both+HBV+infection+and+hepatocellular+carcinoma+development&rft.jtitle=Molecular+carcinogenesis&rft.au=Wen%2C+Juan&rft.au=Liu%2C+Yao&rft.au=Liu%2C+Jibin&rft.au=Liu%2C+Li&rft.date=2015-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0899-1987&rft.eissn=1098-2744&rft.volume=54&rft.issue=11&rft.spage=1275&rft_id=info:doi/10.1002%2Fmc.22200&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3837274601 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-1987&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-1987&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-1987&client=summon |